Your provider will recommend the right approach based on your results, tolerability, and weight maintenance goals
Important Information This product is intended strictly for laboratory research use only
Biological determinations (steroid structure, binding affinity of estrogens to estrogen receptors alpha (ER) and ER beta () for instance) have allowed the comparison of all compounds that affect cellular growth and function
Because of this, retatrutide is thought to be more effective than Wegovy, which only binds to GLP-1 receptors, and Mounjaro, which is a dual agonist that mimics the effects of GLP-1 and GIP
Table of Contents Why GLP-1 Medications May Cause Increased Urination Common Urinary Side Effects of GLP-1 Receptor Agonists When Frequent Urination on GLP-1 Treatment Needs Medical Attention Managing Increased Urination While Taking GLP-1 Medications Other Factors That May Affect Urination During GLP-1 Therapy Scientific References Frequently Asked Questions Why GLP-1 Medications May Cause Increased Urination GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss